U.S. Personal Products Stock News

NasdaqGS:BKNG
NasdaqGS:BKNGHospitality

Assessing Booking Holdings (BKNG) After Recent Share Price Pullback

If you are wondering whether Booking Holdings at around US$3,870 a share still makes sense for your portfolio, or if the market is now mispricing it, this article will walk you through what the current valuation implies. The stock has recently pulled back, with a 6.5% decline over the last 7 days, a 24.1% decline over the last 30 days, a 27.3% decline year to date, and a 22.8% decline over the last year. Over longer periods, the 3 year and 5 year returns stand at 56.1% and 69.5%...
NYSE:ELAN
NYSE:ELANPharmaceuticals

Is Elanco Animal Health (ELAN) Still Attractive After A 123% One Year Share Price Jump

If you are looking at Elanco Animal Health and wondering whether the recent run has already priced in the opportunity, this article will help you frame what the current share price could mean for long term value. The stock finished the last session at US$24.75, with a 1.5% decline over the past week, a 1.4% gain over the past month, a 9.9% gain year to date, and a 122.8% gain over the past year. The 3 year return sits at 113.5% and the 5 year return at a 26.4% decline. These moves have come...
NasdaqGS:POWL
NasdaqGS:POWLElectrical

Powell Industries (POWL) Valuation Check After Strong One Month Share Price Gain

Powell Industries overview Powell Industries (POWL) has drawn investor attention after sizable share price moves, with the stock showing a negative 1 day return of 0.49% and a gain of 30% over the past month. See our latest analysis for Powell Industries. Despite a recent 7 day share price decline of around 7% from its latest close of US$544.15, Powell Industries still shows strong momentum when you look at its 30 day share price return of 30% and a very large 1 year total shareholder return...
NasdaqGM:MIRM
NasdaqGM:MIRMBiotechs

Is It Too Late To Consider Mirum Pharmaceuticals (MIRM) After A 108% One Year Rally?

This article explores whether Mirum Pharmaceuticals, at a share price of US$105.89, may still offer value or whether the current price already reflects a high level of optimism, by examining what the market valuation might be indicating. The stock has delivered returns of 2.7% over the last 7 days, 12.3% over 30 days, 35.6% year to date and 107.8% over 1 year, with a very large 3 year return and a 4.7x gain over 5 years that may have influenced how investors view its risk and reward...
NasdaqGM:FUTU
NasdaqGM:FUTUCapital Markets

Assessing Futu Holdings (NasdaqGM:FUTU) Valuation After Recent Share Price Weakness And 1 Year Return

Futu Holdings (NasdaqGM:FUTU) has drawn investor attention after recent share price weakness, with the stock showing declines over the past month and past 3 months despite a positive 1 year total return. See our latest analysis for Futu Holdings. The recent 1 day share price return of a 5.55% decline and 30 day share price return of a 9.22% decline suggest fading short term momentum, even though the 1 year total shareholder return of 33.07% keeps the longer term picture positive. If Futu’s...
NYSE:BTU
NYSE:BTUOil and Gas

Assessing Peabody Energy (BTU) Valuation After Recent Share Price Pullback And Long Term Gains

Event context and recent share performance Peabody Energy (BTU) shares recently closed at $33.18, with returns over the past month, past 3 months, and year that may catch the eye of investors comparing coal producers in the broader energy sector. See our latest analysis for Peabody Energy. Peabody Energy’s 1 day and 7 day share price returns of 1.04% and 3.69% declines respectively extend a 30 day share price return of 12.59% decline, yet this sits against a 90 day share price return of...
NasdaqGS:PODD
NasdaqGS:PODDMedical Equipment

Insulet Expands Buyback As Shares Trade Below Analyst And Fair Value Estimates

Insulet, NasdaqGS:PODD, has approved a significant increase in its share buyback authorization. The company also extended the duration of its equity repurchase program, giving management more time to execute on the plan. The expanded authorization and longer timeline point to ongoing efforts to return capital to shareholders through repurchases. For investors watching NasdaqGS:PODD, the buyback update comes as the stock trades around $249.38. Recent performance has been mixed, with a 2.7%...
NYSE:APAM
NYSE:APAMCapital Markets

Artisan Partners Expands Alternatives As Valuation Discount And Risks Persist

Artisan Partners Asset Management (NYSE:APAM) is expanding its alternatives platform and pursuing new partnerships to support growth. The company is pushing ahead with these initiatives while facing regulatory headwinds and changing client preferences. This shift in focus is intended to broaden its actively managed offering as more capital moves toward passive products. Artisan Partners has built its business around actively managed strategies, and the move into more alternative offerings...
NasdaqGS:LILA
NasdaqGS:LILATelecom

Liberty Latin America Rebuilds Jamaica Network And Seeks Value In 5G Shift

Liberty Latin America is rebuilding its network in Jamaica after Hurricane Melissa while keeping subscriber and B2B growth on track. The company is rolling out 5G standalone mobile services in partnership with Ericsson. Liberty Latin America is working with AWS on cloud and AI capabilities to support its telecom and enterprise offerings. Liberty Latin America, ticker NasdaqGS:LILA, is drawing attention as it works through major operational disruption while still adding postpaid mobile...
NasdaqGS:WING
NasdaqGS:WINGHospitality

Wingstop Tariffs And Labor Scrutiny Test Valuation And Growth Story

Wingstop (NasdaqGS:WING) is facing new global tariffs announced by the Trump administration, which affect international trade and input costs. The company is also under public scrutiny after a former employee publicly alleged issues with labor and management practices. Social media conversations have amplified these accusations, raising questions for customers, employees, and investors. Wingstop, known for its chicken wing restaurants and franchise model, relies on international supply...
NYSE:FN
NYSE:FNElectronic

Is It Too Late To Consider Fabrinet (FN) After A 169% One Year Surge?

If you are wondering whether Fabrinet's share price still reflects fair value after a strong run, you are not alone. This article will focus squarely on what you might be paying for today. Fabrinet recently closed at US$576.71, with returns of 16.4% over 7 days, 23.5% over 30 days, 20.3% year to date and 169.0% over 1 year, which naturally raises questions about growth potential and changes in perceived risk. Recent coverage around Fabrinet has focused on its position in optical and...
NYSE:CTRA
NYSE:CTRAOil and Gas

Is It Time To Reconsider Coterra Energy (CTRA) After Its Recent Share Price Rally?

If you are wondering whether Coterra Energy is priced attractively at around US$30.75, this article breaks down what the numbers are really saying about the stock’s value. The share price has seen a 12.1% gain over the last 30 days and is up 15.6% year to date, while the 1 year and 5 year returns sit at 13.8% and 110.1% respectively. These changes may have shifted how some investors think about its risk and reward profile. Over the past few months, Coterra has remained in focus as investors...
NYSE:KNSL
NYSE:KNSLInsurance

Assessing Kinsale Capital Group’s Valuation After Strong 2025 Earnings And New US$250 Million Buyback Program

Kinsale Capital Group (KNSL) is back in focus after reporting its fourth quarter and full year 2025 results, alongside a new US$250 million share repurchase plan and continued dividends. See our latest analysis for Kinsale Capital Group. The recent earnings beat, new US$250 million buyback authorization and ongoing dividends come against a softer share price backdrop, with a 30 day share price return of an 8.36% decline and a 1 year total shareholder return of a 12.61% decline, while the 5...
NYSE:V
NYSE:VDiversified Financial

Is It Time To Reassess Visa (V) After Recent Share Price Weakness?

If you are wondering whether Visa is attractively priced or already fully valued, you are not alone. This article will walk through what the current share price might be implying. Visa recently closed at US$306.52, with returns of a 2.4% decline over 7 days, a 6.0% decline over 30 days, an 11.5% decline year to date, and an 11.7% decline over 1 year. The 3 year and 5 year returns sit at 42.3% and 46.8% respectively. Recent headlines around Visa have focused on its role in global payments,...
NYSE:BAH
NYSE:BAHProfessional Services

Is Booz Allen Hamilton (BAH) Pricing Overreacting To Recent Government Contract Headlines

If you are wondering whether Booz Allen Hamilton Holding is attractively priced today, you are not alone. Many investors are asking whether the current share price reflects its long term potential or short term noise. The stock last closed at US$74.26, with returns of a 6.4% decline over 7 days, a 27.4% decline over 30 days, a 12.5% decline year to date, a 32.3% decline over 1 year, a 17.7% decline over 3 years and a 2.6% gain over 5 years, which has changed how some investors may view its...
NYSE:CRS
NYSE:CRSAerospace & Defense

Is It Too Late To Consider Carpenter Technology (CRS) After A 93% One Year Rally?

If you are wondering whether Carpenter Technology's share price still reflects fair value after a strong run, you are not alone. The stock closed at US$385.04, with returns of 1.4% over 7 days, 14.7% over 30 days, 13.8% year to date and 93.0% over the past year, plus a very large gain over 3 and 5 years. Recent headlines around Carpenter Technology have focused on its role as a specialty materials supplier in aerospace and industrial markets, alongside broader interest in suppliers tied to...
NasdaqGS:WGS
NasdaqGS:WGSHealthcare

GeneDx Holdings (WGS) Q4 Loss Of US$17.7 Million Tests Bullish Profitability Narrative

GeneDx Holdings (WGS) closed out FY 2025 with Q4 revenue of US$121.0 million and a basic EPS loss of US$0.61, alongside net income excluding extraordinary items of a US$17.7 million loss. Over recent quarters the company has seen revenue move from US$95.6 million in Q4 2024 to US$121.0 million in Q4 2025, while quarterly basic EPS has ranged from a loss of US$0.31 in Q3 2024 to a gain of US$0.38 in Q2 2025 and back to a loss of US$0.61 in the latest period. This sets up a story in which...
NasdaqGS:INCY
NasdaqGS:INCYBiotechs

Is It Time To Reassess Incyte (INCY) After A 36% One-Year Share Price Gain?

If you are wondering whether Incyte at around US$100.85 is priced for its future or leaving some value on the table, this article walks through what the numbers are really saying about the stock. Over the past week Incyte declined 0.3%. Over 30 days it declined 1.1%. Over the last year it returned 36.3%, with 3-year and 5-year returns of 31.6% and 26.6% respectively. These figures can naturally raise questions about where it sits on the risk and reward spectrum today. Recent headlines around...
NYSE:DGX
NYSE:DGXHealthcare

How Investors May Respond To Quest Diagnostics (DGX) Earnings Beat, Higher Dividend And Expansion Plans

In February 2026, Quest Diagnostics reported higher fourth-quarter and full-year 2025 sales and earnings, issued 2026 guidance calling for US$11.70–US$11.82 billion in revenue and US$9.45–US$9.65 in diluted EPS, raised its quarterly dividend to US$0.86 per share, and disclosed continued share repurchases under its long-running buyback program. The company also signaled continued expansion by pursuing hospital outreach and independent lab acquisitions, while using its questhealth.com platform...
NYSE:FUBO
NYSE:FUBOInteractive Media and Services

Evaluating FuboTV (FUBO) Valuation After Steep Share Price Pressure And Discounted Sales Multiple

FuboTV stock after recent performance FuboTV (FUBO) has been under pressure recently, with the share price at US$1.18 and negative returns over the past week, month, past 3 months and year to date drawing fresh attention from investors. See our latest analysis for FuboTV. The recent 1 day share price return of a 4.84% decline adds to a 30 day share price return of a 52.42% decline and a year to date share price return of a 54.44% decline, which points to fading momentum as investors reassess...
NasdaqGS:BEAM
NasdaqGS:BEAMBiotechs

Beam Therapeutics Taps US$500m Non Dilutive Debt To Back Risto Cel

Beam Therapeutics entered a long term, non dilutive financing agreement with Sixth Street to support the potential launch of its sickle cell gene therapy. The deal provides access to up to $500 million in capital tied to Beam’s commercial plans for this program. The agreement focuses on funding potential product launch and commercialization activities rather than issuing new equity. For investors watching NasdaqGS:BEAM, this financing move comes with the stock trading around $28.33 and a...
NYSE:M
NYSE:MMultiline Retail

What Macy's (M)'s Pre‑Earnings Bearish Options Spike and Insider Selling Means For Shareholders

Macy’s recently saw a surge in bearish options activity and rising caution tied to insider selling and an upcoming earnings report expected on March 5, adding pressure to sentiment around the retailer’s outlook. This comes as Macy’s continues to refresh its assortment and elevate its brand portfolio, including adding more luxury labels under its current leadership team. Next, we’ll examine how this spike in bearish options positioning ahead of earnings could influence Macy’s longer-term...
NasdaqGS:MNDY
NasdaqGS:MNDYSoftware

Is It Time To Reassess monday.com (MNDY) After The Recent Share Price Slide?

If you are wondering whether monday.com is starting to look attractive after a rough stretch, this article will walk through what its current share price might be implying about underlying value. The stock last closed at US$70.13, and has seen a 3.1% decline over 7 days, a 45.8% decline over 30 days, and a 51.1% decline year to date, with a 76.5% decline over the past year and a 55.5% decline over three years. These sharp moves have kept monday.com on many investors' watchlists, as large...
NasdaqGS:ON
NasdaqGS:ONSemiconductor

Assessing ON Semiconductor (NasdaqGS:ON) Valuation As Growth Inflection And Cash Returns Gain Traction

ON Semiconductor (ON) has caught investor attention after management pointed to an inflection in its business, with sequential momentum in automotive, industrial, and AI data centers supported by silicon carbide and gallium nitride products. See our latest analysis for ON Semiconductor. ON Semiconductor’s share price has climbed 12.08% over the past month and 43.80% over the last 90 days, while the 1 year total shareholder return of 30.09% and 5 year total shareholder return of 64.35% point...